Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
Aurogen South Africa (Aurogen), a wholly owned step-down subsidiary of Aurobindo Pharma in South Africa, has entered into an agreement with Novabee Proprietary, to sell and dispose of the entire 50% shares held by Aurogen in Novagen. After the disposal of 50% shares held by Aurogen, Aurogen will cease to be the joint venture partner of Novagen.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content